Skip to main content

Advertisement

Log in

Extubation failure due to atypical parkinsonism with negligible motor and variable non-motor symptoms associated with a variant of DCTN1

  • CE - LETTER TO THE EDITOR
  • Published:
Internal and Emergency Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Abbreviations

PaCO2:

Arterial carbon dioxide partial pressure

anti-IgLON5 antibodies:

Anti-immunoglobulin-like cell adhesion molecule 5 antibodies

P:

Proband

WT:

Wild type

References

  1. Bösel J (2017) Who is safe to extubate in the neuroscience intensive care unit? Semin Respir Crit Care Med 38:830–839. https://doi.org/10.1055/s-0037-1608773

    Article  Google Scholar 

  2. Shimohata T et al (2016) Mechanisms and prevention of sudden death in multiple system atrophy. Parkinsonism Relat Disord 30:1–6. https://doi.org/10.1016/j.parkreldis.2016.04.011

    Article  Google Scholar 

  3. Wittke C et al (2021) Genotype-phenotype relations for the atypical parkinsonism genes: MDSGene systematic review. Mov Disord 36:1499–1510. https://doi.org/10.1002/mds.28517

    Article  CAS  Google Scholar 

  4. Richards S et al (2015) ACMG laboratory quality assurance committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology. Genet Med 17:405–424. https://doi.org/10.1038/gim.2015.30

    Article  Google Scholar 

  5. Tsuboi Y, Mishima T, Fujioka S (2021) Perry disease: concept of a new disease and clinical diagnostic criteria. J Mov Disord. 14:1–9

    Article  Google Scholar 

Download references

Acknowledgements

The authors would like to express their appreciation to Professor Hideshi Kawakami and Dr. Kodai Kume in the Department of Epidemiology, Research Institute for Radiation Biology and Medicine at Hiroshima University for genetical analysis, Professor Takayoshi Shimohata in the Department of Neurology at Gifu University School of Medicine for examining anti-IgLON5 antibodies, and Laboratory Leader Sakae Itoga at Kazusa DNA Research Institute for examining DCTN1 gene.

We also thank for Dr. Masahiro Nakamori, Dr. Shiro Aoki, Dr. Hiroki Ueno, and Dr. Tomohiko Ohshita for their useful contribution.

Funding

There was no targeted funding to report.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shuichiro Neshige.

Ethics declarations

Conflict of interest

The authors have no conflicts of interest to report.

Human and animal rights

This was a retrospective observational single case report, which did not require Institutional Review Board approval at our institution; however, written informed consent was obtained from the patient and his family. All the procedures involving human participants reported herein were performed in accordance with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.

Informed consent

Written informed consent was obtained from the patient for the publication of the case report.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yamada, H., Neshige, S., Morino, H. et al. Extubation failure due to atypical parkinsonism with negligible motor and variable non-motor symptoms associated with a variant of DCTN1. Intern Emerg Med 18, 329–331 (2023). https://doi.org/10.1007/s11739-022-03105-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11739-022-03105-7

Navigation